SCHEMBL2531404

SCHEMBL2531404

COc1cccc(C2Nc3ccc(C(=O)O)cc3CC2(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.42
▸ HDAC8 Q9BY41 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.39
▸ MITF O75030 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ GAA P10253 3/20 0.38
▸ THRB P10828 1/20 0.38
▸ PLA2G1B P04054 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ P4HB P07237 1/20 0.38
▸ DNMT1 P26358 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2535027 0.90 ALDH1A1 (0.44) NPC1HDAC8MAPTMEN1KMT2A
SCHEMBL12219890 0.90 KMO (0.43) MAPTTDP1MEN1KMT2AKDM4E
SCHEMBL12289319 0.89 NR4A1 (0.34) NPC1HDAC8MAPTTDP1MEN1
SCHEMBL2533556 0.87 ALDH1A1 (0.41) NPC1MAPTMEN1KMT2AKDM4E
SCHEMBL2531578 0.87 BCL9 (0.37) CYP2C9LMNA
SCHEMBL2530126 0.86 ALDH1A1 (0.40) MAPTTDP1MEN1KMT2AKDM4E
SCHEMBL2530850 0.84 PARP1 (0.41) MAPTMEN1KMT2AKDM4E
SCHEMBL2532170 0.84 F11 (0.38) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL2527714 0.84 SRD5A1 (0.41) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL12219946 0.84 NR4A2 (0.34) KMT2AALDH1A1MRGPRX4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 — — EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 — — US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 — — EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 — — US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 — — US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 — — WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 NPC1 429/4885HDAC8 1881/4885MAPT 3094/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 NPC1 429/4885HDAC8 1881/4885MAPT 3094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback